Sha W |
[How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis]. |
2014 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:25537407
|
Evans SE et al. |
The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. |
2014 |
PLoS ONE |
pmid:24595451
|
Dechert-Schmitt AM et al. |
Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition. |
2014 |
Nat Prod Rep |
pmid:24514754
|
Kumar S et al. |
Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. |
2013 |
Bioorg. Med. Chem. Lett. |
pmid:23474387
|
Singh R et al. |
No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. |
2013 |
AIDS |
pmid:23014518
|
Rosette C et al. |
Anti-inflammatory and immunomodulatory activities of rifamycin SV. |
2013 |
Int. J. Antimicrob. Agents |
pmid:23756321
|
Falkinham JO et al. |
Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. |
2012 |
Tuberculosis (Edinb) |
pmid:22209468
|
Calatayud M et al. |
In vitro study of transporters involved in intestinal absorption of inorganic arsenic. |
2012 |
Chem. Res. Toxicol. |
pmid:22214486
|
Farrell DJ et al. |
In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21149623
|
Borsali E et al. |
[Ornithinimicrobium pekingense ocular infection]. |
2011 |
Med Mal Infect |
pmid:21440391
|
Shao Z et al. |
Identification and functional analysis of a nitrate assimilation operon nasACKBDEF from Amycolatopsis mediterranei U32. |
2011 |
Arch. Microbiol. |
pmid:21424691
|
Di Stefano AF et al. |
Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21402860
|
Woods LA et al. |
Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. |
2011 |
Nat. Chem. Biol. |
pmid:21873994
|
Yuan H et al. |
Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B. |
2011 |
Acta Biochim. Biophys. Sin. (Shanghai) |
pmid:21986914
|
Zhao J et al. |
Preparation and application of rifamycin-capped (3-(2-O-β-cyclodextrin)-2-hydroxypropoxy)-propylsilyl-appended silica particles as chiral stationary phase for high-performance liquid chromatography. |
2010 |
Talanta |
pmid:21035677
|
Vigliaroli E et al. |
Double pathological fracture of mandibula caused by actinomycotic osteomyelitis: a case report. |
2010 |
Minerva Stomatol |
pmid:20940689
|
Velichka D et al. |
Experimental and clinical studies on Rifacinna--the new effective antituberculous drug (review). |
2010 |
Recent Pat Antiinfect Drug Discov |
pmid:19929844
|
Sharma P et al. |
Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. |
2010 |
Xenobiotica |
pmid:19919292
|
Swift B et al. |
Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes. |
2010 |
Pharm. Res. |
pmid:20652625
|
Mariner KR et al. |
Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20660693
|